NO20035352L - Legemidler for eosinofile sykdommer - Google Patents
Legemidler for eosinofile sykdommerInfo
- Publication number
- NO20035352L NO20035352L NO20035352A NO20035352A NO20035352L NO 20035352 L NO20035352 L NO 20035352L NO 20035352 A NO20035352 A NO 20035352A NO 20035352 A NO20035352 A NO 20035352A NO 20035352 L NO20035352 L NO 20035352L
- Authority
- NO
- Norway
- Prior art keywords
- medicines
- eosinophilic diseases
- eosinophilic
- diseases
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/2878—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the NGF-receptor/TNF-receptor superfamily, e.g. CD27, CD30, CD40, CD95
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
- C07K2317/73—Inducing cell death, e.g. apoptosis, necrosis or inhibition of cell proliferation
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Immunology (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Tropical Medicine & Parasitology (AREA)
- Virology (AREA)
- Genetics & Genomics (AREA)
- Pulmonology (AREA)
- Transplantation (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- AIDS & HIV (AREA)
- Dermatology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2001190083 | 2001-06-22 | ||
PCT/JP2002/006219 WO2003000286A1 (fr) | 2001-06-22 | 2002-06-21 | Remedes pour maladies eosinophiliques |
Publications (2)
Publication Number | Publication Date |
---|---|
NO20035352D0 NO20035352D0 (no) | 2003-12-01 |
NO20035352L true NO20035352L (no) | 2004-02-19 |
Family
ID=19028907
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20035352A NO20035352L (no) | 2001-06-22 | 2003-12-01 | Legemidler for eosinofile sykdommer |
Country Status (11)
Country | Link |
---|---|
US (1) | US20040156847A1 (no) |
EP (1) | EP1405645A4 (no) |
JP (1) | JPWO2003000286A1 (no) |
CN (1) | CN1518459A (no) |
AU (1) | AU2002315848B2 (no) |
BR (1) | BR0210578A (no) |
CA (1) | CA2451138A1 (no) |
IL (1) | IL159478A0 (no) |
NO (1) | NO20035352L (no) |
NZ (1) | NZ530001A (no) |
WO (1) | WO2003000286A1 (no) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2005018571A2 (en) * | 2003-08-20 | 2005-03-03 | University Of Miami | Compositions and methods for treating inflammatory lung disease |
BRPI0607203A2 (pt) * | 2005-02-18 | 2009-08-25 | Medarex Inc | anticorpo anti-cd30 isolado, célula hospedeira, métodos para inibir o crescimento de células cd30+, e, uso de um anticorpo anti-cd30 desfucosilado |
CA2605508A1 (en) * | 2005-05-12 | 2006-11-23 | Wisconsin Alumni Research Foundation | Blockade of pin1 prevents cytokine production by activated immune cells |
ES2611307T3 (es) | 2005-08-30 | 2017-05-08 | University Of Miami | Inmunomodulación de agonistas, antagonistas e inmunotoxinas del receptor del factor de necrosis tumoral 25 (TNFR25) |
EP2462165B1 (en) | 2009-08-03 | 2016-05-11 | University of Miami | Method for in vivo expansion of t regulatory cells |
CN108324943B (zh) * | 2012-02-10 | 2024-03-08 | 思进股份有限公司 | Cd30+癌症的检测和治疗 |
CA2897826C (en) | 2013-01-09 | 2022-09-27 | Taylor H. Schreiber | Compositions and methods for the regulation of t regulatory cells using tl1a-ig fusion protein |
KR101611743B1 (ko) * | 2014-10-28 | 2016-04-11 | 인제대학교 산학협력단 | 모세기관지염 후 천식 진단을 위한 마커 및 이의 용도 |
CN110361546A (zh) * | 2019-08-28 | 2019-10-22 | 重庆三峡医药高等专科学校 | 一种检测嗜酸性粒细胞阳离子蛋白的胶体金试纸条 |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5165923A (en) * | 1989-11-20 | 1992-11-24 | Imperial Cancer Research Technology | Methods and compositions for the treatment of hodgkin's disease |
ES2252732T3 (es) * | 1992-05-26 | 2006-05-16 | Immunex Corporation | Nueva citoquina que une cd30. |
AU777634B2 (en) * | 1999-07-28 | 2004-10-28 | Kazuhiro Aoki | Methods of inhibiting osteoclastogenesis |
-
2002
- 2002-06-21 CA CA002451138A patent/CA2451138A1/en not_active Abandoned
- 2002-06-21 WO PCT/JP2002/006219 patent/WO2003000286A1/ja active Application Filing
- 2002-06-21 EP EP02741233A patent/EP1405645A4/en not_active Withdrawn
- 2002-06-21 IL IL15947802A patent/IL159478A0/xx unknown
- 2002-06-21 AU AU2002315848A patent/AU2002315848B2/en not_active Ceased
- 2002-06-21 BR BR0210578-0A patent/BR0210578A/pt not_active IP Right Cessation
- 2002-06-21 CN CNA028125053A patent/CN1518459A/zh active Pending
- 2002-06-21 NZ NZ530001A patent/NZ530001A/en unknown
- 2002-06-21 JP JP2003506929A patent/JPWO2003000286A1/ja active Pending
-
2003
- 2003-12-01 NO NO20035352A patent/NO20035352L/no not_active Application Discontinuation
- 2003-12-19 US US10/739,300 patent/US20040156847A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
AU2002315848B2 (en) | 2008-05-15 |
EP1405645A4 (en) | 2005-02-02 |
NO20035352D0 (no) | 2003-12-01 |
CA2451138A1 (en) | 2003-01-03 |
US20040156847A1 (en) | 2004-08-12 |
CN1518459A (zh) | 2004-08-04 |
JPWO2003000286A1 (ja) | 2004-10-07 |
NZ530001A (en) | 2006-08-31 |
IL159478A0 (en) | 2004-06-01 |
BR0210578A (pt) | 2004-08-10 |
WO2003000286A1 (fr) | 2003-01-03 |
EP1405645A1 (en) | 2004-04-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO20033556D0 (no) | Farmasöytiske preparater | |
EE200300416A (et) | Ravimvorm | |
NO20033143L (no) | Farmasoytisk preparat | |
PT1501534E (pt) | Formulacoes farmaceuticas | |
FI20011478A (fi) | Farmaseuttinen koostumus | |
DK3210637T3 (da) | Infusionssæt | |
DK1383560T4 (da) | Infusionssæt | |
NO20035315D0 (no) | Farmasöytiske kombinasjoner | |
NO20033205L (no) | Terapeutiske kromanforbindelser | |
NO20035627D0 (no) | Farmasöytisk formulering | |
DE50209245D1 (de) | Neuroprotektives medikament | |
FI20022128A0 (fi) | Farmaseuttinen koostumus | |
NO20035352D0 (no) | Legemidler for eosinofile sykdommer | |
NO20031650L (no) | Nye legemidler for leversykdommer | |
FI20012242A0 (fi) | Uudet farmaseuttiset yhdisteet | |
NO20041236L (no) | Farmasoytisk formulering | |
SE0103116D0 (sv) | Pharmaceutical combination | |
SE0102823D0 (sv) | New drug | |
SE0100009D0 (sv) | Therapeutic compounds | |
SE0100007D0 (sv) | Therapeutic compounds | |
SE0100008D0 (sv) | Therapeutic compounds | |
SE0100006D0 (sv) | Therapeutic compounds | |
FI5468U1 (fi) | Farmaseuttinen koostumus | |
DK1330280T3 (da) | Lægemiddelinhalator | |
UA5530S (uk) | Таблетка фармацевтична |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |